Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity of FE 999049 versus GONAL-F in repeated controlled ovarian stimulation cycles
2013-001616-30Phase 3Completed
- Sponsor
- Ferring Pharmaceuticals
- Start
- Aug 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, single-blind trial of follitropin delta and follitropin alfa in infertility (2 arms), sponsored by Ferring Pharmaceuticals. Primary endpoint: Treatment-induced anti-FSH antibodies. Started Aug 2013; status: completed.
02
Drugs
follitropin deltafollitropin alfa
03
Conditions
infertility
Beyond the preview
Go deeper on 2013-001616-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001616-30.